Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Neurology | Psychiatry/Psychology
Search Medical Condition
Memory Loss Clinical Trials
A listing of Memory Loss medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (78) clinical trials
A Placebo-Controlled, Double-Blind, Parallel-Group, 24 Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
The name of this trial is MissionAD1. This 24-month treatment, multicenter, double-blind, placebo-controlled, parallel group, Phase 3 study in participants with Early Alzheimer's Disease (EAD) including mild cognitive impairment (MCI) due to AD/Prodromal AD and the early stages of mild AD will be conducted to evaluate the efficacy and safety ...
Mild Alzheimers Registry
Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials.
Mild Alzheimer's
A 24-month, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer’s Disease (The AMARANTH Study).
A Phase 3, double blind, randomized study of RVT-101 versus placebo when added to existing stable donepezil treatment in subjects with mild to moderate Alzheimer’s disease; RVT-101-3001
This Study is for patients that have mild to moderate Alzheimer's disease that are on a stable therapy with donepezil.
Long-Term Observational Study for Memory Loss
Do you or a loved one have concerns about recent memory loss or cognitive decline? Clinical Trials of Texas, Inc. is conducting a long-term observational study in which volunteers can be evaluated and followed to assess their current cognitive state and cognitive function (memory loss) over time. Qualified participants will ...
A Multi-center, Double-blind, Randomized, Placebo-controlled Study for the Efficacy of Phosphatidylserine in Mild Cognitive Impairment (MCI)
The primary objective is to evaluate the efficacy and safety of phosphatidylserine (PS) on cognitive abilities in MCI
A Study of LY3314814 in Participants With Mild Alzheimer's Disease Dementia (DAYBREAK-ALZ)
DAYBREAK-ALZ — the study will last 8 weeks to see if you qualify, plus 3 years of treatment, then 4 weeks of follow-up. The study drug is a tablet, to be taken once a day. The tablet will contain either a lower dose of the study drug, a higher dose ...
Clinical Research for Patient with Mild Cognitive Impairment due to Alzheimer's Disease or Mild to Moderate Alzheimer’s Disease disease
If you qualify, the study may involve 3 screening visits, 1 separate in-clinic stay of 5 days/4 nights and 10 outpatient visits. All study exams and procedures are provided at no cost to you. You do not need medical insurance to participate.
Are you Suffering from Memory Loss?
24 month study for patients with mild Alzheimer's disease.
Have you had memory loss?
For some people, dementia and Alzheimer’s disease (AD) can make them feel restless or upset. The ITI-007-201 Agitation Study is looking at an investigational medication to see if it is safe and works well to help reduce how often people with dementia, including AD feel upset or anxious. If you ...
